Capital Expenditures - Vivos Therapeutics Inc (NASDAQ:VVOS) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 2.07 USD -1.43%

Updated:

Vivos Therapeutics Inc
Capital Expenditures

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Vivos Therapeutics Inc
Capital Expenditures Peer Comparison

DVA

DGX

CVS

CI

LH

Company		Capital Expenditures	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Vivos Therapeutics Inc NASDAQ:VVOS	Capital Expenditures -$803k	CAGR 3-Years -88%	CAGR 5-Years 8%	CAGR 10-Years N/A
	DaVita Inc NYSE:DVA	Capital Expenditures -$541.3m	CAGR 3-Years 7%	CAGR 5-Years 11%	CAGR 10-Years 1%
	Quest Diagnostics Inc NYSE:DGX	Capital Expenditures -$385m	CAGR 3-Years 3%	CAGR 5-Years -2%	CAGR 10-Years -4%
	CVS Health Corp NYSE:CVS	Capital Expenditures -$2.8B	CAGR 3-Years -3%	CAGR 5-Years -4%	CAGR 10-Years -3%
	Cigna Corp NYSE:CI	Capital Expenditures -$1.5B	CAGR 3-Years -11%	CAGR 5-Years -19%	CAGR 10-Years -10%
	Laboratory Corporation of America Holdings NYSE:LH	Capital Expenditures -$493.5m	CAGR 3-Years -10%	CAGR 5-Years -4%	CAGR 10-Years -9%

See Also

Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Capital Expenditures amounts to -803k USD.

Over the last year, the Capital Expenditures growth was 13%. The average annual Capital Expenditures growth rates for Vivos Therapeutics Inc have been -88% over the past three years , 8% over the past five years .

Join more than 141,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.